Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O M Colvin

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Seminars in Oncology|October 31, 1997
Drug resistance in the treatment of sarcomasO M Colvin
Current Pharmaceutical Design|September 2, 1999
An overview of cyclophosphamide development and clinical applicationsO M Colvin
Cancer Treatment and Research|January 1, 1994
Mechanisms of resistance to alkylating agentsO M Colvin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Metabolic jeopardy with high-dose cyclophosphamide?--not so fastW P Petros, O M Colvin
Clinics in Haematology|February 1, 1986
Pharmacological purging of bone marrow with reference to autograftingG W Santos, O M Colvin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Ifosfamide: should the honeymoon be over?B A Kamen, E Frenkel, O M Colvin
Cancer Research|May 1, 1991
Specificity of isozymes of murine hepatic glutathione S-transferase for the conjugation of glutathione with L-phenylalanine mustardM G Bolton, O M Colvin, J Hilton
Biomedical & Environmental Mass Spectrometry|April 1, 1990
Characterization of glutathione conjugates of chlorambucil by fast atom bombardment and thermospray liquid chromatography/mass spectrometryD M Dulik, O M Colvin, C Fenselau
Toxicology and Applied Pharmacology|February 1, 1973
Mass spectrometric study of the distribution of cyclophosphamide in humansJ H Duncan, O M Colvin, C Fenselau
Progress in Clinical and Biological Research|January 1, 1989
The role of aldehyde dehydrogenase isozymes in cellular resistance to the alkylating agent cyclophosphamideJ E Russo, J Hilton, O M Colvin
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Seminars in Oncology|October 31, 1997
Drug resistance in the treatment of sarcomasO M Colvin
Current Pharmaceutical Design|September 2, 1999
An overview of cyclophosphamide development and clinical applicationsO M Colvin
Cancer Treatment and Research|January 1, 1994
Mechanisms of resistance to alkylating agentsO M Colvin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Metabolic jeopardy with high-dose cyclophosphamide?--not so fastW P Petros, O M Colvin
Clinics in Haematology|February 1, 1986
Pharmacological purging of bone marrow with reference to autograftingG W Santos, O M Colvin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Ifosfamide: should the honeymoon be over?B A Kamen, E Frenkel, O M Colvin
Cancer Research|May 1, 1991
Specificity of isozymes of murine hepatic glutathione S-transferase for the conjugation of glutathione with L-phenylalanine mustardM G Bolton, O M Colvin, J Hilton
Biomedical & Environmental Mass Spectrometry|April 1, 1990
Characterization of glutathione conjugates of chlorambucil by fast atom bombardment and thermospray liquid chromatography/mass spectrometryD M Dulik, O M Colvin, C Fenselau
Toxicology and Applied Pharmacology|February 1, 1973
Mass spectrometric study of the distribution of cyclophosphamide in humansJ H Duncan, O M Colvin, C Fenselau
Progress in Clinical and Biological Research|January 1, 1989
The role of aldehyde dehydrogenase isozymes in cellular resistance to the alkylating agent cyclophosphamideJ E Russo, J Hilton, O M Colvin
Pageof 13